医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
3期
115-116
,共2页
缩宫素%米索前列醇%子宫%产后出血%护理
縮宮素%米索前列醇%子宮%產後齣血%護理
축궁소%미색전렬순%자궁%산후출혈%호리
oxytocin%misoprostol%womb%postpartum hemorrhage%Nurse
目的：观察米索前列醇协同缩宫素对预防产后出血的临床疗效并总结护理方法与体会。方法选取我院2008年1月至2013年1月宫产产妇240例，所有产妇均排除以下疾病：肝脏疾病、心脑血管疾病、各类产后出血高危因素、前列醇使用禁忌、凝血机制障。然后随机将产妇分为治疗组和对照组，对照组产妇剖宫产后立即予肌肉缩宫素，治疗组在对照组的基础上，加用米索前列醇片，依次观察两组患者产后出血的发生率、出血量以及子宫收缩的情况。两组均在用药后予综合护理并分析两组护理、治疗效果及不良反应等情况。结果治疗组产后2h及24h出血量及出血发生率明显低于对照组，差异具有统计学意（P<0.01），子宫收缩情况优于对照组(P<0.05)。结论米索前列醇协同缩宫素并给予综合性护理，疗效优于单独缩宫素治疗，可明显减少产后出血量和出血率，不良反应少，安全有效，值得临床推广使用。
目的：觀察米索前列醇協同縮宮素對預防產後齣血的臨床療效併總結護理方法與體會。方法選取我院2008年1月至2013年1月宮產產婦240例，所有產婦均排除以下疾病：肝髒疾病、心腦血管疾病、各類產後齣血高危因素、前列醇使用禁忌、凝血機製障。然後隨機將產婦分為治療組和對照組，對照組產婦剖宮產後立即予肌肉縮宮素，治療組在對照組的基礎上，加用米索前列醇片，依次觀察兩組患者產後齣血的髮生率、齣血量以及子宮收縮的情況。兩組均在用藥後予綜閤護理併分析兩組護理、治療效果及不良反應等情況。結果治療組產後2h及24h齣血量及齣血髮生率明顯低于對照組，差異具有統計學意（P<0.01），子宮收縮情況優于對照組(P<0.05)。結論米索前列醇協同縮宮素併給予綜閤性護理，療效優于單獨縮宮素治療，可明顯減少產後齣血量和齣血率，不良反應少，安全有效，值得臨床推廣使用。
목적：관찰미색전렬순협동축궁소대예방산후출혈적림상료효병총결호리방법여체회。방법선취아원2008년1월지2013년1월궁산산부240례，소유산부균배제이하질병：간장질병、심뇌혈관질병、각류산후출혈고위인소、전렬순사용금기、응혈궤제장。연후수궤장산부분위치료조화대조조，대조조산부부궁산후립즉여기육축궁소，치료조재대조조적기출상，가용미색전렬순편，의차관찰량조환자산후출혈적발생솔、출혈량이급자궁수축적정황。량조균재용약후여종합호리병분석량조호리、치료효과급불량반응등정황。결과치료조산후2h급24h출혈량급출혈발생솔명현저우대조조，차이구유통계학의（P<0.01），자궁수축정황우우대조조(P<0.05)。결론미색전렬순협동축궁소병급여종합성호리，료효우우단독축궁소치료，가명현감소산후출혈량화출혈솔，불량반응소，안전유효，치득림상추엄사용。
Objective To observe the synergy oxytocin misoprostol for the prevention of postpartum hemorrhage and summarizes the clinical efficacy of nursing and experience. Methods 240 cases from January 2008 to 2013, al women were excluded from the fol owing diseases: liver disease, cardiovascular disease, various types of risk factors for postpartum hemorrhage, epoprostenol use of taboo, impaired clotting mechanism. Then randomly divided into treatment group and control group,The control group immediately after cesarean section to muscle oxytocin treatment group were based on the addition of misoprostol tablets, fol owed by postpartum were observed the incidence of bleeding, bleeding and uterine contractions situation. After treatment in both groups and analyze two integrated care nursing, therapeutic effects and adverse reactions and so on.Result Treatment group 2h and 24h post-partum bleeding and bleeding rate was significantly lower than the control group, the difference was statistical y significant (P<0.01), uterine contraction than the control group (P<0.05). Conclusion Misoprostol Oxytocin together and give comprehensive care, more effective than oxytocin alone treatment can significantly reduce postpartum bleeding volume and rate of adverse reactions, safe, effective and worthy of clinical use.
